the antibacterial activity of n-formimidoyl thienamycin ( mk0787 ) was evaluated in 335 clinical isolates of ampicillin-resistant enterobacteriaceae , 50 pseudomonas aeruginosa strains , 28 acinetobacter spp. , 50 streptococcus faecalis strains , and 7 oxacillin-resistant staphylococcus aureus strains and was compared with the recently developed beta-lactam antibiotics mezlocillin , cefuroxime , cefazedone , cefoperazone , cefotaxime , and moxalactam .
C0007562
cefuroxime
C0007554
cefotaxime